Development of the Swedish anticholinergic burden scale (Swe-ABS)

BACKGROUND: Drugs with anticholinergic properties are associated with cognitive adverse effects, especially in patients vulnerable to central muscarinic antagonism. A variety of drugs show weak, moderate or strong anticholinergic effects. Therefore, the cumulative anticholinergic burden should be co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rube, Tanja, Ecorcheville, Astrid, Londos, Elisabet, Modig, Sara, Johansson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464171/
https://www.ncbi.nlm.nih.gov/pubmed/37626293
http://dx.doi.org/10.1186/s12877-023-04225-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464171/
https://www.ncbi.nlm.nih.gov/pubmed/37626293
http://dx.doi.org/10.1186/s12877-023-04225-1

Ejemplares similares